CIK: 1238970 - Address: C/o Osi Pharmaceuticals, Inc., 420 Saw Mill River Rd., Ardsley, NY 10502
43 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/18/09 09:54
3/16/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2938.630-1-516
2/17/09 20:10
2/17/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-3040.240-1-417
1/16/09 14:09
1/15/09
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2837.680-1-417
12/16/08 14:23
12/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2533.150-1-418D
11/18/08 15:43
11/17/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2736.220-1-419D
10/16/08 14:57
10/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-3040.210-1-420D
9/16/08 16:14
9/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d1515.0201520D
9/16/08 16:14
9/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-8749.570-2-820D
8/19/08 17:29
8/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d1817.6701521D
8/19/08 17:29
8/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-9252.830-2-821D
7/17/08 17:32
7/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d2020.3101522D
7/17/08 17:32
7/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-7945.000-2-722D
7/11/08 15:47
7/10/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d7120.31041823D
7/11/08 15:47
7/10/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-15845.000-4-1323D
6/17/08 13:49
6/16/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-3039.700-1-323D
5/19/08 12:36
5/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2736.640-1-321D
4/16/08 14:33
4/15/08
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-2836.730-1-322D
10/4/05 17:07
10/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d2020.3101129D
10/4/05 17:07
10/3/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-4429.070-2-149D
9/6/05 17:40
9/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d3332.79011210D
9/6/05 17:40
9/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-4932.790-2-1410D
8/3/05 13:53
8/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d2020.31011110D
8/3/05 13:53
8/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-6341.810-2-1310D
7/6/05 10:50
7/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d2020.31011011D
7/6/05 10:50
7/1/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-5939.500-2-1211D
6/15/05 10:12
6/13/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d2020.31011011D
6/15/05 10:12
6/13/05
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-5738.280-2-1211D
12/10/04 16:46
12/9/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d566.750832611D
12/10/04 16:46
12/9/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-37545.000-8-4311D
12/3/04 16:49
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d286.75046211D
12/3/04 16:49
12/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-20148.320-4-2811D
11/29/04 17:04
11/24/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d1847.3502511D
11/29/04 17:04
11/24/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-1,70250.050-34-7611D
11/2/04 19:43
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d399.25042720D
11/2/04 19:43
11/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-33264.340-5-2120D
10/5/04 14:45
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d399.25042521D
10/5/04 14:45
10/1/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-31661.090-5-2021D
9/17/04 17:11
9/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d399.25042422D
9/17/04 17:11
9/15/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-32362.500-5-1922D
8/20/04 17:23
8/19/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM.d363.630102649D
8/20/04 17:23
8/19/04
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS.d-58258.190-10-1749D
8/22/03 16:57
8/21/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDM254.13063722D
8/22/03 16:57
8/21/03
OSIPOsi Pharmaceuticals IncDEHealthDiagnIn Vitro & In Vivo DiagnosticWhite John PNYDS-43336.110-12-3522D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact